Get breaking news alerts via email

Click here to manage your alerts
Myriad’s shares finish down after Supreme Court ruling

First Published Jun 13 2013 10:56 am • Last Updated Jun 13 2013 04:02 pm

Shares of diagnostic test maker Myriad Genetics Inc. fell Thursday after the Supreme Court issued a mixed ruling in a case involving the company’s patents on genes at the center of its proprietary tests for increased risk of breast and ovarian cancer.

Myriad’s shares on the Nasdaq stock exchange were up most of the day, including more than 10 percent at one point, but fell into negative territory in the final hour of trading. The share price plunged as much as 10 percent but recovered enough to finish the day at $32.01, down 5.63 percent.

Join the Discussion
Post a Comment

Myriad, based in Salt Lake City, sells a test for a specific gene linked to breast cancer — the only test had been available for those genes. They were challenged, leading to the Supreme Court’s review, even though the U.S. Patent and Trademark Office has been awarding patents on human genes for almost 30 years.

The high court ruled that genes naturally found in the body cannot be patented, but that synthetically created genetic material, called cDNA, can be patented. That leaves an opening for Myriad to continue making money, Justice Clarence Thomas wrote in the court’s majority decision.

Patents give inventors the right to prevent others from making, using or selling a novel device, process or application, usually for a number of years.

Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Top Reader Comments Read All Comments Post a Comment
Click here to read all comments   Click here to post a comment

About Reader Comments

Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
Staying Connected
Contests and Promotions
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.